Phase I/II Radiation Dose-Escalation Trial of Intensity Modulated Radiotherapy (IMRT) with Concurrent Fixed Dose-Rate Gemcitabine (FDR-G) for Unresectable Pancreatic Cancer

被引：4
|
作者：
Ben-Josef, E. [1 ]
Schipper, M. [1 ]
Francis, I. [1 ]
Khan, G. [1 ]
Hadley, S. [1 ]
Lawrence, T. [1 ]
Simeone, D. [1 ]
Abrams, R. [2 ]
Sonnenday, C. [1 ]
Zalupski, M. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S127 / S128
页数：2
相关论文
共 50 条
  • [31] Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy
    Nakamura, Akira
    Shibuya, Keiko
    Nakamura, Mitsuhiro
    Matsuo, Yukinori
    Shiinoki, Takehiro
    Nakata, Manabu
    Mizowaki, Takashi
    Hiraoka, Masahiro
    MEDICAL PHYSICS, 2013, 40 (02)
  • [32] Phase II study of induction chemotherapy with fixed dose rate (FDR) gemcitabine and cisplatin followed by concurrent chemoradiation with capecitabine for locally advanced pancreatic cancer (LAPC)
    Kim, J.
    Im, S.
    Park, H.
    Chie, E.
    Hwang, J.
    Kim, J.
    Kim, T.
    Bang, Y.
    Ha, S.
    Yoon, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic carcinoma
    Espinosa, E.
    Feliu, J.
    de Castro, J.
    Belda, C.
    Casado, E.
    Herrero, A.
    Sereno, M.
    Pinto, A.
    Gomez, C.
    Baron, M. Gonzalez
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Conformal radiotherapy in pancreatic cancer: A phase I/II dose escalation study.
    Geh, JI
    Wells, P
    Williamson, RCN
    Dunn, P
    Dale, R
    Price, PM
    BRITISH JOURNAL OF CANCER, 1999, 80 : 62 - 62
  • [35] Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma
    Van Buren, George
    Ramanathan, Ramesh K.
    Krasinskas, Alyssa M.
    Smith, Ryan
    Abood, Gerard J.
    Shuai, Yongli
    Potter, Douglas M.
    Bahary, Nathan
    Lembersky, Barry C.
    Zureikat, Amer H.
    Bartlett, David L.
    Zeh, Herbert
    Moser, Arthur J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [36] Phase II Trial of Fixed-dose Rate Gemcitabine, Bevacizumab, and Concurrent 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
    Van Buren, G.
    Ramanathan, R. K.
    Krasinskas, A.
    Smith, R.
    Abood, G.
    Shuai, Y.
    Potter, D. P.
    Bahary, N.
    Lembersky, B. C.
    Zureikat, A. H.
    Zeh, H. J.
    Bartlett, D. L.
    Moser, A. J.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S150 - S150
  • [37] A phase I trial of full-dose gemcitabine, oxaliplatin, and radiation therapy for unresectable pancreatic cancer: Preliminary analysis
    Feng, F. Y.
    Griffith, K. A.
    Murphy, J. D.
    Francis, I. R.
    Desai, S. P.
    Lawrence, T. S.
    Zalupski, M. M.
    Ben-Josef, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S308 - S309
  • [38] Fixed dose rate (FDR) gemcitabine (G) and capecitabine (C) in patients with metastatic biliary tract cancer (BTC): Final results of phase II trial
    Santini, D.
    Vincenzi, B.
    Vasile, E.
    Catalano, V.
    Virzi, V.
    Masi, G.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma
    Carneiro, Benedito A.
    Brand, Randall E.
    Fine, Elita
    Knop, Richard H.
    Khandekar, Janardan D.
    Uhlig, William
    Locker, Gershon Y.
    CANCER INVESTIGATION, 2007, 25 (05) : 366 - 371
  • [40] A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
    Chen, Justin A.
    Huynh, Jasmine C.
    Wu, Chun-Yi
    Yu, Ai-Ming
    Matsukuma, Karen
    Semrad, Thomas J.
    Gandara, David R.
    Li, Tianhong
    Riess, Jonathan W.
    Tam, Kit
    Mack, Philip C.
    Martinez, Anthony
    Mahaffey, Nichole
    Kelly, Karen L.
    Kim, Edward J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (03) : 217 - 228
12345